The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise

Background: treated prostate cancer (PCa) patients develop biochemical recurrence (BCR) in 27–53% of cases; the role of MRI in this setting is still controversial. In 2021 a panel of experts proposed a “Prostate Imaging-Recurrence Reporting” (PI-RR) score, aiming to standardize the reporting. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergaglio, Chiara, Giasotto, Veronica, Marcenaro, Michela, Barra, Salvina, Turazzi, Marianna, Bauckneht, Matteo, Casaleggio, Alessandro, Sciabà, Francesca, Terrone, Carlo, Mantica, Guglielmo, Borghesi, Marco, Signori, Alessio, Spina, Bruno, Piol, Nataniele, Zanardi, Elisa, Fornarini, Giuseppe, Zawaideh, Jeries Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914595/
https://www.ncbi.nlm.nih.gov/pubmed/36766492
http://dx.doi.org/10.3390/diagnostics13030387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914595/
https://www.ncbi.nlm.nih.gov/pubmed/36766492
http://dx.doi.org/10.3390/diagnostics13030387

Ejemplares similares